CCL20 and hepatocellular carcinoma: In addition, CCL20 expression is associated with HCC recurrence and patient survival, which may be expressed through the PI3K/AKT and Wnt/β‐catenin signaling pathways, which induce EMT and promote HCC cell proliferation and migration [34].